Viewing Study NCT02581995


Ignite Creation Date: 2025-12-24 @ 2:10 PM
Ignite Modification Date: 2026-02-23 @ 9:22 PM
Study NCT ID: NCT02581995
Status: COMPLETED
Last Update Posted: 2018-10-10
First Post: 2015-10-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-11-19
Start Date Type: ACTUAL
Primary Completion Date: 2017-08-09
Primary Completion Date Type: ACTUAL
Completion Date: 2017-08-09
Completion Date Type: ACTUAL
First Submit Date: 2015-10-20
First Submit QC Date: None
Study First Post Date: 2015-10-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-07-26
Results First Submit QC Date: None
Results First Post Date: 2018-10-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-09-12
Last Update Post Date: 2018-10-10
Last Update Post Date Type: ACTUAL